# Mineralys Therapeutics, Inc. (MLYS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MLYS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -39.34M | $ -39.47M | $ 0 | $ 638.14M |
| 2025 | $ 0 | $ -158.35M | $ -145.84M | $ 0 | $ 646.69M |
| 2024 | $ 0 | $ -186.89M | $ -174.91M | $ 0 | $ 191.26M |
| 2023 | $ 0 | $ -77.74M | $ -87.77M | $ 0 | $ 241.15M |
| 2022 | $ 0 | $ -33.29M | $ -32.64M | $ 0 | $ -52.27M |
| 2021 | $ 0 | $ -8.42M | $ -5.81M | $ 0 | $ -22.93M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.02 |
| Current Ratio | 44.33 |

## Other views

- [Metrics](https://sponda.capital/en/MLYS.md)
- [Charts](https://sponda.capital/en/MLYS/charts.md)
- [Compare](https://sponda.capital/en/MLYS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.